Cipla Peer Comparison

NSE: CIPLA | BSE: 500087

₹1,419.90

₹16.10 (1.15%)

As on 11-Nov-2026 15:55IST

Market cap

₹1,14,243 Cr

Revenue (TTM)

₹28,139 Cr

P/E Ratio

39.4

P/B Ratio

3.2

Div. Yield

0.9 %

Edit

	Cipla	Sun Pharmaceutical	Torrent Pharma	Zydus Lifesciences	Dr. Reddy'S Labs
Market cap (₹ Cr)	1,14,243	4,54,362	1,81,171	1,19,700	1,14,754
Revenue (₹ Cr)	28,139	61,631	17,400	30,378	33,097
Net Profit (₹ Cr)	2,868.29	11,037.19	2,099.00	4,159.00	2,759.70
Net Margin (%)	9.94	17.23	12.10	13.20	8.03
RoE (%)	8.90	14.23	16.47	16.61	7.30
Price to Earnings	39.43	41.43	85.30	28.64	40.99
Price-To-Book	3.23	5.09	9.86	4.30	2.96

Income Statement (₹ Cr)

	Cipla	Sun Pharmaceutical	Torrent Pharma	Zydus Lifesciences	Dr. Reddy'S Labs
Operating Revenue	28,138.89	61,630.92	17,400.00	30,378.10	33,097.40
Total Income	28,855.45	64,063.12	17,348.00	31,504.60	34,352.50
Total Expenditure	23,306.78	43,720.59	11,626.00	22,828.30	28,236.90
EBITDA	4,832.11	17,910.33	5,774.00	7,549.80	4,860.50
Depreciation	1,352.39	3,004.86	1,916.00	2,027.20	2,141.40
EBIT	3,479.72	14,905.47	3,858.00	5,522.60	2,719.10
Interest	60.93	338.59	886.00	595.90	450.40
Other Income	716.56	2,432.20	-52.00	1,126.50	1,255.10
Exceptional Items	-275.91	-1,962.40	-107.00	-499.30	0.00
Profit before Tax	3,859.44	15,036.68	2,813.00	5,553.90	3,523.80
Provision for Tax	991.15	3,999.49	714.00	1,394.90	764.10
Profit after Tax	2,868.29	11,037.19	2,099.00	4,159.00	2,759.70

	Cipla	Sun Pharmaceutical	Torrent Pharma	Zydus Lifesciences	Dr. Reddy'S Labs
Shareholder's Funds	35,395.50	89,279.88	18,373.00	27,817.30	38,807.00
Minority Interest	43.21	-20.97	25.00	-101.90	40.20
Non-Current Liabilities	935.18	1,683.12	18,258.00	7,260.60	3,074.90
Current Liabilities	6,976.93	23,591.58	7,984.00	18,023.50	15,430.30
Total Liabilities	42,342.71	1,08,407.20	43,613.69	50,672.60	56,576.70

	Cipla	Sun Pharmaceutical	Torrent Pharma	Zydus Lifesciences	Dr. Reddy'S Labs
Non-Current Assets	16,372.16	44,135.45	33,165.00	36,142.90	26,891.10
Current Assets	25,060.80	69,266.58	10,517.00	18,433.50	29,732.20
Total Assets	42,342.71	1,08,407.20	43,613.69	50,672.60	56,576.70
Total Debt*	257.97	4,081.61	14,798.24	11,769.50	7,734.10
Net Current Assets	18,083.87	45,675.00	2,533.00	410.00	14,301.90
Contingent Liabilities	987.37	1,587.05	379.25	989.90	336.14

	Cipla	Sun Pharmaceutical	Torrent Pharma	Zydus Lifesciences	Dr. Reddy'S Labs
Cash From Operating Activities	3,940.02	12,419.18	3,022.71	2,116.60	5,673.70
Cash Flow from Investing Activities	-2,326.13	-11,344.05	-12,712.41	-8,296.10	-6,549.30
Cash from Financing Activities	-1,233.65	-2,512.55	10,150.60	5,806.90	829.00
Net Cash Inflow / Outflow	380.24	-1,437.42	460.90	-372.60	-46.60

	Cipla	Sun Pharmaceutical	Torrent Pharma	Zydus Lifesciences	Dr. Reddy'S Labs
ROCE (%)	16.00	19.11	19.27	21.39	13.75
ROE (%)	8.90	14.23	16.47	16.61	7.30
ROA (%)	6.86	10.10	6.98	8.11	4.93
EBIT Margin (%)	12.37	24.19	22.17	18.18	8.22
Net Margin (%)	9.94	17.23	12.10	13.20	8.03
Cash Profit Margin (%)	0.00	0.00	0.00	0.00	0.00

	Cipla	Sun Pharmaceutical	Torrent Pharma	Zydus Lifesciences	Dr. Reddy'S Labs
Revenue Growth (%)	-0.74	12.13	42.06	24.02	-3.53
EBIT Growth (%)	-42.59	7.78	21.02	-16.48	-58.47
Net Profit Growth (%)	-47.41	4.94	-1.92	-16.41	-51.77
EPS Growth (%)	-42.93	6.57	-1.09	-10.25	-51.50
Book Value Growth (%)	10.59	15.72	10.51	13.19	12.99

	Cipla	Sun Pharmaceutical	Torrent Pharma	Zydus Lifesciences	Dr. Reddy'S Labs
Price / Earnings	36.57	37.16	75.37	26.66	41.29
Price / Book Value	3.21	5.12	9.89	4.35	2.98
Dividend Yield (%)	0.92	0.84	0.80	0.08	0.58
EV/EBITDA	21.70	23.93	33.67	16.63	23.95
Market Cap (₹ Cr)	98,797.18	4,21,639.92	1,42,851.87	87,643.18	1,04,763.81

	Cipla	Sun Pharmaceutical	Torrent Pharma	Zydus Lifesciences	Dr. Reddy'S Labs
Debt to Equity	0.00	0.00	0.63	0.15	0.00
Short term debt to equity ratio	0.00	0.05	0.35	0.16	0.16
Current Ratio	3.59	2.94	1.32	1.02	1.93
Quick Ratio	2.62	2.40	0.92	0.64	1.40
Interest Coverage	64.34	45.41	4.17	10.32	8.82

	Cipla	Sun Pharmaceutical	Torrent Pharma	Zydus Lifesciences	Dr. Reddy'S Labs
Debtors to sales (%)	21.32	28.89	19.53	14.42	30.64
Asset Turnover	0.67	0.56	0.58	0.59	0.59
Receivable days	52.05	89.14	45.41	33.55	103.79
Inventory Days	57.25	67.85	52.67	33.80	79.94
Payable days	115.96	213.72	244.06	149.82	84.78
Cash Conversion Cycle	-6.65	-56.72	-145.98	-82.46	98.95

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.